CATALYST DOSSIER · UPDATED 2026-11-04
$EBS biotech · convergence 7 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $EBS?
Quantitative
Net Income (CY2026Q2) : $-180.2M (n/a YoY)
Catalysts
Deal terms : milestone_payment 2026-11-02
Risks
Position-sizing discipline : Conviction WATCH (7 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Sympathy basket (cerebro)
PCOR via tech r=+0.86 sympathetic (score 24) BLZE via tech r=+0.86 sympathetic (score 23) REED via staples r=-0.81 divergent (score 16) CHSN via staples r=-0.81 divergent (score 13) AMD via semis r=+0.77 sympathetic (score 22) DIOD via semis r=+0.77 sympathetic (score 18)
Signals Firing
finra_short gap auto_macro_adp_payrolls auto_macro_durable_goods auto_macro_fx_rates
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-16 sec_top_gappers +3.1% -0.3% ✓ hit 2026-10-16 sec_top_moat_emerging +3.1% -0.3% ✓ hit 2026-10-07 sec_top_gappers -0.8% -3.7% — 2026-10-07 sec_top_moat_emerging -0.8% -3.7% —
Lifetime: 2/4 wins · hit-rate 50.0% on +2% intraday
Sympathy Basket PCOR via tech · score 24 BLZE via tech · score 23 REED via staples · score 16 CHSN via staples · score 13 AMD via semis · score 22 DIOD via semis · score 18 Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.